Peter Greenleaf, Chief Executive Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 18,136 shares at $12.01 ($218K) on 2022-03-02, disclosed to the SEC on 2022-03-04.
Open-market sale of $218k AUPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 9,068 | $109K | 50.0% |
| 2 | $12.01 | 9,068 | $109K | 50.0% |
| Total | $12.01 avg | 18,136 | $218K | 100% |
| Filing → |
| AUPH | SELL | 2025-03-04 | $4.2M | — | Filing → |
| AUPH | SELL | 2024-03-07 | $1.4M | — | Filing → |
| AUPH | SELL | 2024-02-22 | $580K | — | Filing → |